Clinical and pathological features of 13 adult patients with pulmonary Langerhans‘ cell histiocytosis

F. S. Oymak, N. Tutar, H. Buyukoglan, M. Bilgin, S. Balkanli, E. Mavili, R. Demir, I. Gulmez (Kayseri, Turkey)

Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Session: Clinical aspects of diffuse parenchymal lung disease
Session type: Thematic Poster Session
Number: 729
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. S. Oymak, N. Tutar, H. Buyukoglan, M. Bilgin, S. Balkanli, E. Mavili, R. Demir, I. Gulmez (Kayseri, Turkey). Clinical and pathological features of 13 adult patients with pulmonary Langerhans‘ cell histiocytosis. Eur Respir J 2009; 34: Suppl. 53, 729

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical features and outcome of adult patients with pulmonary Langerhans cell histiocytosis
Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Year: 2019

Clinical, functional and morphologic features in patients with pulmonary Langerhans‘ cell histiocytosis (nonsmokers and smokers)
Source: Annual Congress 2009 - Tobacco: from smoke to disease
Year: 2009


Psychological abnormalities are commonly present in adult patients with pulmonary Langerhans cell histiocytosis
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019


Clinical course and outcome of pulmonary Langerhans‘-cell histiocytosis
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010

Pulmonary Langerhans histiocytosis: clinical, radiological and functional pattern in spontaneous remission
Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Year: 2009

Pulmonary Langerhans‘ cell histiocytosis (PLCH). Report of two cases diagnosed with pulmonary vascular involvement via exercise tests
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008


Clinical study of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012

Langerhans’ cell granulomatosis: clinical manifestations and prognosis of pulmonary lesions
Source: Eur Respir J 2004; 24: Suppl. 48, 49s
Year: 2004

Clinical and morphological signs of liver damadge in patients with pulmonary sarcoidosis
Source: Annual Congress 2011 - Different profiles of sarcoidosis and other granulomatous disorders
Year: 2011

Pathological findings in histiocytosis X with pulmonary hypertension
Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV
Year: 2012

Adult pulmonary Langerhans‘ cell histiocytosis and lung cancer
Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer
Year: 2009

Analysis of the clinical and pathological features of 10 patients with pulmonary sclerosing hemangioma
Source: Eur Respir J 2005; 26: Suppl. 49, 538s
Year: 2005

Pulmonary langerhans¢ cell histiocytosis (LCH) - a retrospective review of 17 patients
Source: Eur Respir J 2003; 22: Suppl. 45, 43s
Year: 2003

Ventilation disorders dynamics and morphological changes in patients with pulmonary Langerhans cell histiocytosis (PLCH)
Source: International Congress 2015 – IIPs: orphan
Year: 2015


Clinical impact of BRAFV600E mutation in adult pulmonary Langerhans cell histiocytosis
Source: International Congress 2019 – Towards a better understanding of rare diffuse parenchymal lung diseases
Year: 2019



Clinical and functional characteristics of patients with unclassifiable interstitial lung diseases (uILD) from eurIPFreg.
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


Incidence, clinical manifestations and prognosis of cardiac sarcoidosis in patients with pulmonary sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013


Langerhans' cell histiocytosis: clinical and diagnostic features and response to therapy
Source: Eur Respir J 2001; 18: Suppl. 33, 219s
Year: 2001

Pulmonary Langerhans‘ cell histiocytosis (PLCH): A new UK register
Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis
Year: 2012


Clinico-radiological diagnosis of atypical forms of pulmonary sarcoidosis
Source: International Congress 2017 – Various imaging modalities for different lung diseases
Year: 2017